Johnson, Kimberly A., PhD
- Title: Research Associate Professor
- Phone: (813) 974-4430
- Office: MHC2737
- Send email
- Curriculum Vitae
Kimberly A. Johnson, Ph. D., is a research associate professor in the Department of Mental Health Law and Policy at the Louis de la Parte Florida Mental Health Institute, in the College of Behavioral and Community Sciences at USF. In addition to her research and teaching duties, Dr. Johnson serves as the executive director of the International Consortium of Universities for Drug Demand Reduction, a newly formed international membership organization for universities with addiction studies programs.
Dr. Johnson earned her PhD in population health from the University of Wisconsin, Madison. Her research has focused on quality improvement and implementation science in behavioral health. She has received funding by NIDA, AHRQ, Robert Wood Johnson Foundation, and the California Endowment to study adoption of process improvement practices, adoption of medication assisted treatment in addiction treatment programs, adoption of other evidence based practices and the barriers and facilitators of change. Her interest in the intersection of research and quality improvement has led to her use of large data sets to identify targets for improvement at the system, provider organization and individual patient levels.
Her research has also involved the use of technology to improve efficiency and effectiveness in patient care and to improve the adoption and utilization of evidence based treatments and she has received funding from NIDA, NIMH and AHRQ for these projects.
Prior to her appointment at USF, Dr. Johnson was the director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration, part of the Department of Health and Human Services for the U.S. government where she helped develop the department’s opioid strategy and managed the country’s three billion dollar substance abuse treatment budget.
She has worked as an associate scientist at the University of Wisconsin, Madison where her projects included acting as the co-director of the national coordinating office of the Addiction Technology Transfer Centers (ATTC)and as co-deputy director of NIATx in addition to the previously mentioned research projects. She has also served as the state of Maine single state authority for substance abuse, and as the executive director of a substance abuse treatment agency. In her early career, Dr. Johnson was a child and family therapist and managed treatment and prevention programs.
Dr. Johnson’s dedication and contributions to the behavioral health field earned her numerous awards and she is a highly-regarded thought leader. She has authored a variety of publications on topics important to addiction and recovery including co-authoring a chapter on quality in the ASAM Principles of Addiction Medicine text and a book: The NIATx Model: Process Improvement in Behavioral Health.
- PhD Population Health, University of Wisconsin, Madison
- MBA, University of Southern Maine
- MSEd Counselor Education, University of Southern Maine
- Quality Improvement in behavioral health
- Quality Measurement
- Systems design
- Implementation Science
- Technology adoption by behavioral health patients and providers
- Impact of technology on efficiency and effectiveness of care
Johnson, K., Jones, C., Compton, W., Baldwin, G., Fan, J., Mermin, J., & Bennett, J. (2018). Federal Response to the Opioid Crisis. Current HIV/AIDS Reports. http:https://doi.org/10.1007/s11904-018-0398-8
Williams, A. R., Nunes, E. V., Bisaga, A., Pincus, H. A., Johnson, K. A., Campbell, A. N., Remien, R. H., et al. #40;2018). Developing an opioid use disorder treatment cascade: A review of quality measures. Journal of Substance Abuse Treatment.
Blanco, C., Compton, W., Han, B., Jones, C., & Johnson, K. A. (2018). Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the US. Neuropsychopharmacology< (Vol. 43, pp. S638-S638).
Compton, W. M., Han, B., Blanco, C., Johnson, K., & Jones, C. M. (2018). Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States. American Journal of Psychiatry, appi-ajp.
Muroff, J., Robinson, W., Chassler, D., López, L. M., Gaitan, E., Lundgren, L., & Johnson, K. (2017). Use of a Smartphone Recovery Tool for Latinos with Co-Occurring Alcohol and Other Drug Disorders and Mental Disorders. Journal of Dual Diagnosis,13(4) 280-90.
Scott, C. K., Dennis, M. L., Gustafson, D., & Johnson, K. (2017). A pilot study of the feasibility and potential effectiveness of using smartphones to provide recovery support. Drug & Alcohol Dependence, 171, e185.
Johnson, K., Richards, S., Chih, M. Y., Moon, T. J., Curtis, H., & Gustafson, D. H. (2016). A Pilot Test of a Mobile App for Drug Court Participants. Substance Abuse: Research and Treatment, 10 (1).
Johnson K, Gustafson D, Ewigman B, et al. (2015). Using Rapid-Cycle Research to Reach Goals: Awareness, Assessment, Adaptation, Acceleration. AHRQ Publication No. 15-0036. Rockville (MD): Agency for Healthcare Research and Quality.
Johnson, K., Quanbeck, A., Maus, A., Gustafson, D. H., & Dearing, J. W. (2015). Influence networks among substance abuse treatment clinics: implications for the dissemination of innovations. Translational Behavioral Medicine, 5(3), 260-268
Johnson K, Ford J, & McClusky M. (2012). Promoting new practices to increase access to and retention in addiction treatment: An analysis of five communication channels. Addictive Behaviors 37(11), 1193–1197
Johnson, K., Isham, A., Shah, D. V., & Gustafson, D. H. (2011). Potential roles for new communication technologies in treatment of addiction. Current psychiatry reports, 13(5), 390-397.